PubMed:17293353 / 179-326
Annnotations
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":147},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":147},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":147},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Gangliosides (GGs), involved in malignant alteration and tumor progression/invasiveness, are considered as tumor biomarkers or therapeutic targets."}
PubmedHPO
{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":57,"end":62},"obj":"HP_0002664"},{"id":"T2","span":{"begin":107,"end":112},"obj":"HP_0002664"}],"text":"Gangliosides (GGs), involved in malignant alteration and tumor progression/invasiveness, are considered as tumor biomarkers or therapeutic targets."}
mondo_disease
{"project":"mondo_disease","denotations":[{"id":"T2","span":{"begin":57,"end":62},"obj":"Disease"},{"id":"T3","span":{"begin":107,"end":112},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"Gangliosides (GGs), involved in malignant alteration and tumor progression/invasiveness, are considered as tumor biomarkers or therapeutic targets."}
GlyCosmos15-HP
{"project":"GlyCosmos15-HP","denotations":[{"id":"T1","span":{"begin":57,"end":62},"obj":"Phenotype"},{"id":"T2","span":{"begin":107,"end":112},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0002664"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0002664"}],"text":"Gangliosides (GGs), involved in malignant alteration and tumor progression/invasiveness, are considered as tumor biomarkers or therapeutic targets."}
GlyCosmos15-MONDO
{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T2","span":{"begin":57,"end":62},"obj":"Disease"},{"id":"T3","span":{"begin":107,"end":112},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"Gangliosides (GGs), involved in malignant alteration and tumor progression/invasiveness, are considered as tumor biomarkers or therapeutic targets."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":147},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":147},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":147},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Gangliosides (GGs), involved in malignant alteration and tumor progression/invasiveness, are considered as tumor biomarkers or therapeutic targets."}
GlyCosmos15-Sentences
{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T2","span":{"begin":0,"end":147},"obj":"Sentence"}],"text":"Gangliosides (GGs), involved in malignant alteration and tumor progression/invasiveness, are considered as tumor biomarkers or therapeutic targets."}
HP-phenotype
{"project":"HP-phenotype","denotations":[{"id":"T1","span":{"begin":57,"end":62},"obj":"Phenotype"},{"id":"T2","span":{"begin":107,"end":112},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0002664"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0002664"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Gangliosides (GGs), involved in malignant alteration and tumor progression/invasiveness, are considered as tumor biomarkers or therapeutic targets."}